• Citer

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

par Burstein, Harold H.J.;Curigliano, Giuseppe;Loibl, Sibylle;Dubsky, Peter;Gnant, Michael;Poortmans, Philipp;Colleoni, Marco Angelo;Denkert, Carsten;Piccart-Gebhart, Martine ;Regan, Meredith;Senn, Hans-Jörg;Winer, Eric;Thürlimann, Beat
Référence Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 30, 10, page (1541-1557)
Publication Publié, 2019-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
Auteur:	Burstein, Harold H.J.; Curigliano, Giuseppe; Loibl, Sibylle; Dubsky, Peter; Gnant, Michael; Poortmans, Philipp; Colleoni, Marco Angelo; Denkert, Carsten; Piccart-Gebhart, Martine; Regan, Meredith; Senn, Hans-Jörg; Winer, Eric; Thürlimann, Beat
Informations sur la publication:	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 30, 10, page (1541-1557)
Statut de publication:	Publié, 2019-10
Sujet CREF:	Cancérologie
	Hématologie
Mots-clés:	early breast cancer
	radiation therapy
	St. Gallen Consensus
	surgery
	systemic adjuvant therapies
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:1569-8041
	info:doi/10.1093/annonc/mdz235
	info:scp/85075090438
	info:pmid/31373601